Deferasirox for managing iron overload in people with myelodysplastic syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Deferasirox for Managing Iron Overload in People With Myelodysplastic Syndrome." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 19 April 2024.
Deferasirox for managing iron overload in people with myelodysplastic syndrome. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed April 19, 2024.
Deferasirox for managing iron overload in people with myelodysplastic syndrome. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Deferasirox for Managing Iron Overload in People With Myelodysplastic Syndrome [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Deferasirox for managing iron overload in people with myelodysplastic syndrome
ID - 434021
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434021/all/Deferasirox_for_managing_iron_overload_in_people_with_myelodysplastic_syndrome_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -